Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: A systematic review and network meta-analysis.

چکیده

We evaluate conbercept, ranibizumab, and laser therapy for retinopathy of prematurity (ROP) through 53 studies (14 RCTs, 29 retrospective, 10 single-arm) involving 8787 eyes. Primary endpoints included inactive ROP rates (resolution of plus disease/vascular tortuosity), disease regression,…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• درمان های ضد VEGF
• رتینوپاتی نارسی